More
    Guided Solutions - Connecting Talent With Innovation/div>

    Philips zeroes in on stroke care with AI partnership and new triage study

    With an estimated 1 in 4 people over the age of 25 expected to have a stroke at some point in their lives, it...

    DarioHealth touts data for diabetes management platform

    DarioHealth (NSDQ:DRIO) recently presented data supporting its artificial intelligence (AI)-powered diabetes management platform. New York-based Dario’s research examined users who were given access to a new...

    Sequana Medical Announces Positive Results From Second Interim Analysis of North American Pivotal alfapump® Study (POSEIDON)

    Interim data from 26 patients in the Roll-In Cohort reconfirm positive outcomes against all primary endpointsiOver 90% reduction in mean frequency of therapeutic paracentesis...

    £1.6m human v machine knee surgery study to take place

    A national study will pitch human skill against machine precision as it compares the benefits of knee replacement surgery performed using a robot to...

    Medtronic touts trial results for InPen smart insulin pen, extended infusion system

    Medtronic (NYSE:MDT) today presented positive study results for its InPen smart insulin pen and its extended-wear infusion set. Fridley, Minn.-based Medtronic touted real-world clinical results comparing...

    CardieX subsidiary’s SphygmoCor device chosen for Yale University clinical trial

    ATCOR's SphygmoCor XCEL device will be used in Yale University’s clinical trial focused on maternal health. Hypertension during pregnancy is an indicator of severe maternal...

    Relievant Medsystems Announces Publication of New INTRACEPT Trial Data Showing Sustained Relief from Chronic Low Back Pain 12 Months Post-Procedure

    Study Results Validate Superiority of Basivertebral Nerve Ablation Compared to Standard Care, With Similar Improvements Demonstrated in Crossover Population Relievant Medsystems, a privately held medical...

    LivaNova Brings the Conversation Back to Neuromodulation with New IDE

    LivaNova is developing the aura6000 System to treat obstructive sleep apnea. The device will be evaluated in the OSPREY RCT Trial. The study comes...

    CorWave Successfully Performed a 90-Day In Vivo Study on Its Revolutionary Cardiac Pump Synchronized With the Native Heart, Results Presented at ASAIO Meeting

    CorWave, a French medical device company committed to the fight against heart failure, announced that it has successfully completed the first 90-day preclinical study...

    Latest articles